“…Moreover, trials that only dosed SM one to two times per day may not have achieved high enough plasma concentrations due to the rapid half-life observed in patients with liver disease. 11 Therefore, if SM exerts any antiviral activity in vivo, it may be transient, and would require adequate plasma and, perhaps more importantly, liver concentrations following repeated daily dosing.…”